Patient Navigator
The START Center for Cancer Research
Summary
The Patient Navigator facilitates patient referrals for the START Phase 1 program. This role involves managing referral documentation, monitoring referral metrics, and supporting outreach activities. The Patient Navigator ensures a smooth intake process and efficient communication with referring providers.
Job description
Essential Responsibilities
- Perform referral intake and assist with patient and provider coordination.
- Maintain referral documentation and monitor referral trends.
- Screen patients using EMR systems and genomic platforms for eligibility.
- Support the Nurse Navigator in program outreach and trial promotion.
- Participate in program meetings and contribute to data tracking efforts.
Required Education and Experience
- High School Diploma or GED.
- Minimum of 2 years of clinical patient referral experience.
- 1 year oncology experience.
Preferred Education and Experience
- Associate's degree in healthcare or related field.
- Clinical trial experience.
Requirements
- High School Diploma or GED
- Minimum of 2 years of clinical patient referral experience
- 1 year oncology experience
- Associate's degree in healthcare or related field (preferred)
- Clinical trial experience (preferred)
Benefits
- 401(k) Matching
- Annual Performance Bonus
- Paid Time Off
- Paid Holidays
- Medical, Dental & Vision
- Life Insurance
- Disability Insurance
- Employee Assistance Program
- Flexible FSA
- HSA Plans
Company overview
The START Center for Cancer Research (START) is a global leader in early-phase oncology clinical trials, providing specialized access to novel anti-cancer therapies through its extensive network of community-based research sites. Founded in Texas in 2007, START has established itself as the world's largest community-based early-phase oncology research organization with operations spanning the United States and Europe. The company operates 10 research locations globally and has conducted over 1,500 early-phase clinical trials, contributing to the development and approval of 45 FDA/EMA-approved cancer therapies. START's unique model embeds clinical trial capabilities within community oncology centers, enabling patients to access cutting-edge treatments where they already receive care. With more than 30 Principal Investigators and over 100,000 square feet of world-class research facilities, the organization focuses on accelerating the transition from clinical trials to approved treatments. START's comprehensive approach includes genetic tumor profiling, targeted therapies, and multi-specialty services, all delivered through a patient-centered framework that prioritizes accessibility and scientific rigor in cancer research.